Publications

Use of a new functional dual coating (FDC) assay to measure low toxin levels in serum and food samples following an outbreak of human botulism.

Jones RGA, Marks JD

Journal of medical microbiology
. Mar 21, 2013
Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor.

Federman N, Chan J, Nagy JO, Landaw EM, McCabe K, Wu AM, Triche T, Kang H, Liu B, Marks JD, Denny CT

Sarcoma
. Sep 11, 2012
Simultaneous and sensitive detection of six serotypes of botulinum neurotoxin using enzyme-linked immunosorbent assay-based protein antibody microarrays.

Zhang Y, Lou J, Jenko KL, Marks JD, Varnum SM

Analytical biochemistry
. Aug 27, 2012
Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.

Meng Q, Garcia-Rodriguez C, Manzanarez G, Silberg MA, Conrad F, Bettencourt J, Pan X, Breece T, To R, Li M, Lee D, Thorner L, Tomic MT, Marks JD

Analytical biochemistry
. Aug 21, 2012
N-Terminal labeling of filamentous phage to create cancer marker imaging agents.

Carrico ZM, Farkas ME, Zhou Y, Hsiao SC, Marks JD, Chokhawala H, Clark DS, Francis MB

ACS nano
. Aug 6, 2012
An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors.

McCabe KE, Liu B, Marks JD, Tomlinson JS, Wu H, Wu AM

Molecular imaging and biology
. Jun 1, 2012
Selection and characterization of cell binding and internalizing phage antibodies.

Zhou Y, Zhao L, Marks JD

Archives of biochemistry and biophysics
. May 22, 2012
Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies.

Zhou Y, Goenaga AL, Harms BD, Zou H, Lou J, Conrad F, Adams GP, Schoeberl B, Nielsen UB, Marks JD

Molecular cancer therapeutics
. May 7, 2012
A functional dual-coated (FDC) microtiter plate method to replace the botulinum toxin LD50 test.

Liu YY, Rigsby P, Sesardic D, Marks JD, Jones RG

Analytical biochemistry
. Mar 6, 2012
Building and characterizing antibody-targeted lipidic nanotherapeutics.

Kirpotin DB, Noble CO, Hayes ME, Huang Z, Kornaga T, Zhou Y, Nielsen UB, Marks JD, Drummond DC

Methods in enzymology
. Jan 1, 2012